<DOC>
	<DOC>NCT01523106</DOC>
	<brief_summary>This is a randomized, double-blind, placebo-controlled study, comparing the effect of L-carnitine vs placebo on fatigue among Crohn's disease patients. The specific aim of this study is to determine if treatment with L-carnitine is more effective than placebo at decreasing fatigue severity scores, while accounting for disease activity and concomitant anemia, depression/anxiety and poor sleep quality.</brief_summary>
	<brief_title>L-carnitine to Treat Fatigue Associated With Crohn's Disease</brief_title>
	<detailed_description>A total of 100 patients will be recruited, in order to be able ensure to detect a significant difference in fatigue between the treatment and control groups.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Patients will have had previously macro and microscopically verified Crohn's disease, as defined by traditional clinical and endoscopic standards. To be included, patients need to have disease which is either in remission or is mild to moderate in severity, as defined by the HarveyBradshaw Index Score (HBI&lt;16). In addition, patients will need to answer "yes" to the screening study entry question ("Is fatigue a signficant problem for you currently?"). Exclusion criteria will include: age &lt;18 or &gt;70 years pregnancy or delivery within 6 months malignancy diagnosed within 1 year oral/intravenous steroid treatment within 6 months any surgery within 6 months presence of a stoma or ileoanal Jpouch anastomosis concurrent hepatitis B or C infection cirrhosis renal insufficiency (CrCl&lt;60) and history of seizure disorder or hypothyrodism. prior to study enrollment women of childbearing age will need to undergo pregnancy testing.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Crohn's disease</keyword>
	<keyword>carnitine</keyword>
</DOC>